MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


SMALL-CAP WINNERS & LOSERS: Hansa rises; Ondo InsurTech loss widens

ALN

The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

----------

SMALL-CAP - WINNERS

----------

Hansa Investment Co Ltd, up 2.6% at 278.00 pence, 12-month range 294.00p-190.00p. The closed-ended investment company says court approves planned all-share merger with investment firm Ocean Wilsons. It notes that Ocean Wilsons will now take steps to submit the final court order to the court for sealing. The firm adds that Ocean Wilsons can only complete the combination once the sealed court order has been issued.

----------

Solvonis Therapeutics PLC, up 3.8% at 0.25p, 12-month range 0.40p-0.11p. The London-based biopharmaceutical company focused on addiction and mental health disorders says its novel compound SVN-015 has been accepted into the US National Institute on Drug Abuse’s addiction treatment discovery programme. The firm says the compound targets methamphetamine and cocaine use disorders. Under the programme, NIDA, which is part of the US National Institutes of Health, will fund and conduct early preclinical evaluation of the compound. ‘Being accepted into NIDA’s ATDP for SVN-015 is a major step forward for Solvonis... For methamphetamine and cocaine addiction - where no approved drug treatments exist - this represents an important advance,’ says Chief Scientific Officer David Nutt.

----------

SMALL-CAP - LOSERS

----------

Ondo InsurTech PLC, down 17% at 24.95p, 12-month range 44.00p-20.67p. The claim prevention technology company says its pretax loss widens to £3.9 million in the six months to the end of September from £2.4 million a year ago. Revenue jumps 26% to £2.1 million from £1.7 million while administrative expenses climb 28% to £3.2 million from £2.5 million. The company says it expects revenue in the current year to be between £4.5 million and £5.0 million and that the earnings before interest, tax, depreciation and amortisation loss will be between £5.0 million and £5.5 million. Ondo ends the period with cash of £600,000. The firm says it intends to secure £2.2 million in a fundraise to new and existing institutional investors and other investors. It says the fundraising will be at a price of 25p per share in a placing to raise not less than £1.4 million, a direct subscription to raise £760,000 and a retail offering to existing shareholders. It says the net proceeds will be used to accelerate the firm’s commercial progress in the US through the expansion of US plumber coverage and infrastructure.

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.